Cite
HARVARD Citation
Huh, W. et al. (2017). Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial. Lancet. 390 (10108), pp. 2143-2159. [Online].